To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Paget's disease of the breast
Paget's disease of the breast, also known as Paget's disease of the nipple, is a condition that outwardly may have the appearance of eczema - with skin changes involving the nipple of the breast. Because of its seemingly innocuous and surface appearance, it often presents late, but it is a condition that may be fatal. Extramammary Paget's disease (EMPD) has the same histologic features as Paget's disease of the breast but different locations. Additional recommended knowledge
SymptomsUsually only affecting one nipple, The first symptom is usually an eczema-like rash. The skin of the nipple and areola may be red and inflamed. Some women have an itching or burning sensation. Fluid (discharge) may leak from the abnormal area of cells. The nipple may turn inwards (be inverted). There may or may not be a lump in the breast there may be redness, oozing and crusting, and a sore that does not heal. DiagnosisRecommended tests are a mammogram and a biopsy to confirm the diagnosis, and cytology may also be helpful. TreatmentTreatment usually involves some kind of mastectomy to surgically remove the tumour. Chemotherapy and/or radiotherapy may be necessary. HistoryThe condition is named after Sir James Paget, an English surgeon who first described it in 1874.
Categories: Dermatology | Types of cancer | Breast |
|||||||||||||||||||||||||||||||||||
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Paget's_disease_of_the_breast". A list of authors is available in Wikipedia. |
- Découverte d'une nouvelle maladie : comment le système immunitaire détruit le cervelet - Une étude identifie de nouveaux auto-anticorps dans le liquide céphalorachidien comme biomarqueur possible de la progression rapide de la cérébellite
- Genmab and Pepscan to identify human antibodies against intractable targets
- Novartis drug Tasigna meets primary endpoint in pivotal trial against Glivec as first-line treatment in chronic myeloid leukemia
- Study reveals effects of chemoradiation in brains of glioblastoma patients
- Microplastics in freshwaters - The risks to the environment are (still) low